#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatocellular carcinoma Mantle cell lymphoma recurrent Necrotising enterocolitis neonatal Muscular dystrophy Lymphatic malformation Fungal infection Osteomyelitis B precursor type acute leukaemia Epstein-Barr virus associated lymphoproliferative disorder Retinoblastoma Fibrosarcoma metastatic Neuropathy peripheral Dermatitis Cold type haemolytic anaemia ABO haemolytic disease of newborn More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis Synovial sarcoma recurrent – Life with Disease Idiopathic pulmonary fibrosis Mantle cell lymphoma stage IV – Diagnostics Mucous membrane pemphigoid – Basic Information Aicardi-Goutieres syndrome – Life with Disease Haemophilia – Diagnostics Short-bowel syndrome – Treatment Familial haemophagocytic lymphohistiocytosis – Life with Disease Haemophilia A with anti factor VIII – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ARLOCABTAGENE AUTOLEUCEL Mps-213 Ads-013 IHMA-2121771-2 Iclepertin Histidine Felis Domesticus (555) LUMC-BOB1-B7-TCR.1 Avutometinib Altizide VENT-03 Tinengotinib Desogestrel Eltrombopag TX000045 Dotatate Dapansutrile Tub-040 Ergocalciferol Bp Melphalan Hydrochloride More therapies…

    Learn about Your Condition

    Infertility male Bone marrow disorder Tardive dyskinesia Hypoglycaemia Bone hypertrophy External cephalic version Ocular lymphoma Nasal sinus cancer Cartilage injury Huntington's disease Peripheral artery restenosis Addison's disease Lysosomal storage disorder Injury Cardiomyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diagnosis

  • Study on Imaging Multiple Myeloma Patients Using Fluciclovine (18F) PET/CT

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Fluciclovine (18F)
    Norway

  • Study on Apathy in Stroke Patients Using Fluoroethoxybenzovesamicol F-18 and Fluorodopa (18F)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Apathy
    • Cerebrovascular accident
    Investigated Drugs:
    • Fluorodopa (18F)
    • Fluoroethoxybenzovesamicol F-18
    France

  • Study on the Safety and Effectiveness of 64Cu-DOTA-AE105 PET Imaging for Patients with Localized, Untreated Prostate Cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 64Cu-Dota-Ae105
    Denmark Germany Sweden

  • Study on 68Ga-FAPI-46 for Predicting Treatment Response in Early-Stage High-Risk Triple-Negative Breast Cancer Patients Undergoing Chemo-Immunotherapy

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    • Cyclophosphamide
    France

  • Study on Placental Blood Flow in Fetal Growth Restriction Using Sulfur Hexafluoride for Patients Undergoing Medical Termination of Pregnancy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Foetal growth restriction
    Investigated Drugs:
    • Sulfur Hexafluoride
    France

  • Study to Compare Non-Radioactive Methods for Measuring Kidney Function in Patients with Chronic Kidney Disease Using Sodium Iotalamate, Sodium Iodohippurate, and Iohexol

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal failure
    • Chronic kidney disease
    Investigated Drugs:
    • Sodium Iotalamate (125I)
    • Epinephrine
    • Clemastine
    The Netherlands
Previous Page
1 … 5 6 7 8 9 … 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!